Literature DB >> 11122818

Novel antineoplastic agents.

R M Bukowski1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11122818     DOI: 10.1007/s11912-000-0004-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  1 in total

1.  Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors.

Authors:  S G Eckhardt; J Rizzo; K R Sweeney; G Cropp; S D Baker; M A Kraynak; J G Kuhn; M A Villalona-Calero; L Hammond; G Weiss; A Thurman; L Smith; R Drengler; J R Eckardt; J Moczygemba; A L Hannah; D D Von Hoff; E K Rowinsky
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.